Dominant negative Ubiquitin-conjugating enzyme E2C sensitizes cervical cancer cells to radiation

International Journal of Radiation Biology

Volumn 88, Issue 9, 2012, Pages 629-634

  Bose, Mayil Vahanan ^a   Gopal, Gopisetty ^a   Selvaluxmy, Ganesharaja ^a   Rajkumar, Thangarajan ^a  

^a CANCER INSTITUTE WIA   (India)

Author keywords

Cervical cancer; Dominant negative UBE2C; Radiation sensitivity; Therapeutic target; UBE2C

Indexed keywords

3 4,5 DIMETHYLTHIAZOL 2 YL 5 3 CARBOXYMETHOXYPHEN 2 4 SULFOPHENYL 2H TETRAZOLIUM; AGAR; TETRAZOLIUM; UBIQUITIN CONJUGATING ENZYME E2; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; CANCER CELL; CANCER RADIOTHERAPY; CELL PROLIFERATION; CELL SURVIVAL; CHEMOSENSITIZATION; CLONING; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; GROWTH CURVE; GROWTH RATE; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIVITY; UTERINE CERVIX CANCER;

CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; RADIATION TOLERANCE; UBIQUITIN-CONJUGATING ENZYMES; UTERINE CERVICAL NEOPLASMS;

EID: 84865728708     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2012.702299     Document Type: Article

References (20)

1. Bastians H, Topper LM, Gorbsky GL, Ruderman JV . 1999. Cell cycleregulated proteolysis of mitotic target proteins . Molecular Biology of the Cell 10 : 3927 - 3941
2. Chen S, Chen Y, Hu C, Jing H, Cao Y, Liu X . 2010. Association of clinicopathological features with UbcH10 expression in colorectal cancer . Journal of Cancer Research and Clinical Oncology 136 : 419 - 426
3. Chung YM, Kim BG, Park CS, Huh SJ, Kim J, Park JK, Cho SM, Kim BS, Kim JS, Yoo YD, Bae DS . 2005. Increased expression of ICAM-3 is associated with radiation resistance in cervical cancer . International Journal of Cancer 117 : 194 - 201
4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM . 2010. GLOBOCAN 2008 Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 Lyon France : International Agency for Research on Cancer . Available from: Http://globocan.iarc.fr
5. Glickman MH, Ciechanover A . 2002. The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction . Physiological Reviews 82 : 373- 428.
6. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, Williams CJ . 2001. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis . The Lancet 358 : 781 - 786
7. Guerriero E, Ferraro A, Desiderio D, Pallante P, Berlingieri M. T, Iaccarino A, Palmieri E, Palombini L, Fusco A, Troncone G . 2010 UbcH10 expression on thyroid fi ne-needle aspirates . Cancer Cytopathology 118 : 157 - 165
8. Kadara H, Lacroix L, Behrens C, Solis L, Gu X, Lee JJ, Tahara E, Lotan D, Hong WK, Wistuba II, Lotan R . 2009. Identifi cation of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis system . Cancer Prevention Research (Philadelphia PA,USA) 2 : 702 - 711
9. Lin J, Raoof DA, Wang Z, Lin MY, Th omas DG, Greenson JK, Giordano TJ, Orringer MB, Chang AC, Beer DG, Lin L, 2006. Expression and eff ect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma . Neoplasia 8 : 1062- 1071.
10. Loussouarn D, Campion L, Leclair F, Campone M, Charbonnel C, Ricolleau G. Gouraud W, Bataille R, Jezequel P . 2009. Validation of UBE2C protein as a prognostic marker in node-positive breast cancer . British Journal of Cancer 101 : 166- 173.
11. Madura K, Prakash S, Prakash L . 1990. Expression of the Saccharomyces cerevisiae DNA repair gene RAD6 that encodes a ubiquitin conjugating enzyme increases in response to DNA damage and in meiosis but remains constant during the mitotic cell cycle . Nucleic Acids Research 18 : 771- 778.
12. Okamoto Y, Ozaki T, Miyazaki K, Aoyama M, Miyazaki M, Nakagawara A . 2003. UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme . Cancer Research 63 : 4167 - 4173
13. Rajkumar T, Sabitha K, Vijayalakshmi N, Shirley S, Bose MV, Gopal G, Selvaluxmy G . 2011. Identifi cation and validation of genes involved in cervical tumourigenesis . BMC Cancer 11 : 80.
14. Rajkumar T, Vijayalakshmi N, Sabitha K, Shirley S, Selvaluxmy G, Bose MV, Nambaru L . 2009. A 7 gene expression score predicts for radiation response in cancer cervix . BMC Cancer 9 : 365
15. Saxena A, Yashar C, Taylor DD, Gercel-Taylor C . 2005. Cellular response to chemotherapy and radiation in cervical cancer . American Journal of Obstetrics and Gynecology 192 : 1399 - 1403
16. Shekhar MP, Lyakhovich A, Visscher DW, Heng H, Kondrat N . 2002. Rad6 overexpression induces multinucleation centrosome amplifi cation abnormal mitosis aneuploidy and transformation . Cancer Research 62 : 2115- 2124.
17. Th un MJ, DeLancey JO, Center MM, Jemal A, Ward EM . 2010. The global burden of cancer: Priorities for prevention . Carcinogenesis 31 : 100 - 110
18. Townsley FM, Aristarkhov A, Beck S, Hershko A, Ruderman JV . 1997 Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/ UbcH10 blocks cells in metaphase . Proceedings of the National Academy of Sciences of the USA 94 : 2362 - 2367
19. Troncone G, Guerriero E, Pallante P, Berlingieri MT, Ferraro A, Del Vecchio L, Gorrese M, Mariotti E, Iaccarino A, Palmieri EA, Zeppa P, Palombini L, Fusco A . 2009. UbcH10 expression in human lymphomas . Histopathology 54 : 731- 740.
20. Warrenfeltz S, Pavlik S, Datta S, Kraemer ET, Benigno B, McDonald JF . 2004. Gene expression profi ling of epithelial ovarian tumours correlated with malignant potential . Molecular Cancer 3 : 27